[image_with_animation image_url=”9988″ animation=”Fade In” hover_animation=”none” alignment=”center” border_radius=”none” box_shadow=”none” image_loading=”default” max_width=”100%” max_width_mobile=”default” img_link=”https://www.microbiometimes.com/fda-lifts-hold-on-maat-pharmas-phase-3-investigational-nda-for-maat013-in-patients-with-acute-graft-versus-host-disease/”]